Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,248
Closed -$305K 730
2024
Q4
$305K Sell
4,248
-271
-6% -$21.2K 0.02% 534
2024
Q3
$361K Buy
4,519
+162
+4% +$13K 0.02% 462
2024
Q2
$338K Buy
4,357
+247
+6% +$18.5K 0.02% 460
2024
Q1
$322K Buy
4,110
+223
+6% +$16.6K 0.02% 438
2023
Q4
$277K Sell
3,887
-163
-4% -$11.3K 0.02% 445
2023
Q3
$285K Sell
4,050
-157
-4% -$11.9K 0.03% 394
2023
Q2
$338K Buy
4,207
+98
+2% +$8.01K 0.04% 351
2023
Q1
$341K Buy
4,109
+549
+15% +$44.2K 0.05% 303
2022
Q4
$277K Buy
+3,560
New +$254K 0.04% 353
2022
Q3
Sell
-6,039
Closed -$419K 389
2022
Q2
$419K Sell
6,039
-451
-7% -$33.5K 0.09% 162
2022
Q1
$494K Buy
+6,490
New +$467K 0.11% 145

Other funds holding HOLX

Wedmont Private Capital's HOLX Position: Q1 2025 in Review

Wedmont Private Capital sold out of Hologic (HOLX) in Q1 2025, closing a stake of 4,248 shares — an estimated $305K sold.

Wedmont Private Capital first reported a position in HOLX in Q1 2022 and held it in 11 quarters. The position peaked at $494K in Q1 2022. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Wedmont Private Capital reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Wedmont Private Capital sold 4,248 Hologic shares in Q1 2025, an estimated $305K.
  • Wedmont Private Capital first reported a position in Hologic in Q1 2022 and held it in 11 quarters.
  • Wedmont Private Capital's Hologic position peaked at $494K in Q1 2022.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Wedmont Private Capital's 13F filing for Q1 2025, filed 14 Apr 2025.